We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

May 28, 2010

American Sales Company, Inc. v. Novo Nordisk A/S et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. November 18, 2014

    Novo Nordisk Pays $19M To Settle Prandin Antitrust Action

    Novo Nordisk A/S has agreed to pay $19 million to settle a putative class action in Michigan federal court accusing it of attempting to monopolize the market for popular diabetes treatment Prandin by pursuing sham infringement litigation against generic-drug makers.

1 other articles on this case. View all »

Parties

To view the parties, register now.